Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Ascendis Pharma Oncology Division A/s

Clinical trials sponsored by Ascendis Pharma Oncology Division A/s, explained in plain language.

Ascendis Pharma Oncology Division A/S ASND NASDAQ

Biopharmaceutical company focused on oncology therapies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Terminated 1

New immune drug shows promise in early trial for Hard-to-Treat cancers

Disease control Ongoing

This study tests an experimental drug called TransCon IL-2 β/γ, which aims to boost the immune system to fight cancer. It is given alone or with other treatments like pembrolizumab (Keytruda) or chemotherapy. The trial includes 320 adults with advanced solid tumors that have not …

Phase: PHASE1, PHASE2 • Sponsor: Ascendis Pharma Oncology Division A/S • Aim: Disease control

Last updated Jun 27, 2026 09:07 UTC